Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Accelerated Phase × Axitinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 20 Kidney Neoplasms 6 Neoplasms 5 Uterine Cervical Neoplasms 3 Neoplasm Metastasis 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Melanoma 2 Endometrial Neoplasms 2 Clear-cell metastatic renal cell carcinoma 2 Carcinoma, Non-Small-Cell Lung 2 cT2a N0NxM0 Renal Tumor 1 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Radiation Therapy 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Kidney Diseases 1 Gastrointestinal Stromal Tumors 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Cystadenocarcinoma, Serous 1 Colorectal Neoplasms 1

Interventions

Cyclophosphamide 8 fludarabine phosphate 5 Methotrexate 5 ponatinib 4 Whole-Body Irradiation 4 merphos 3 Tacrolimus 3 Rituximab 3 Peripheral Blood Stem Cell Transplantation 3 Mycophenolic Acid 3 CT-P10 3 Busulfan 3 letermovir 2 Vincristine 2 Melphalan 2 Cytarabine 2 Cyclosporine 2 venetoclax 1 prednylidene 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 deltacortene 1 bosutinib 1 blinatumomab 1 auricularum 1 Vorinostat 1 Valganciclovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡